tldrdailynews.com logo

"Is Eli Lilly Poised to Become the First $1 Trillion Pharma Stock?"

1 min read
Source: Yahoo Finance
"Is Eli Lilly Poised to Become the First $1 Trillion Pharma Stock?"
Photo: Yahoo Finance
TL;DR Summary

Matt Higgins, RSE Ventures Co-Founder and CEO, recommends Eli Lilly (LLY) as a top pick for investors to capitalize on the growing GLP-1 drug market due to its potential for growth, pipeline of obesity drugs, and the high rate of obesity in America. He advises avoiding PepsiCo (PEP) due to the potential impact of GLP-1 drugs on snack food sales, the company's slow pivot to healthier options, and recent revenue declines.

Topics:business#eli-lilly#finance#glp-1-drugs#obesity#pepsico#pharmaceuticals
Share this article
  1. Why Eli Lilly is a top pick to capitalize on GLP-1 drug craze  Yahoo Finance
  2. Lilly's Climb Has Morgan Stanley Asking $1 Trillion Question  Yahoo Finance
  3. Morgan Stanley ponders if Eli Lilly could be the first $1 trillion pharma stock on weight loss boom  CNBC
  4. Will Weight-Loss, Diabetes Drugs Drive LLY Stock Into $1 Trillion Club?  Investor's Business Daily
  5. Lilly Stock’s Upside Prompts Morgan Stanley to Ask if It Can Reach $1 Trillion  Barron's

Reading Insights

Total Reads

0

Unique Readers

10

Time Saved

8 min

vs 9 min read

Condensed

96%

1,760 → 71 words

Want the full story? Read the original article

Read on Yahoo Finance